Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: Report from the Children's Oncology Group

  • Cisplatin Dose in Medulloblastoma
  • Amulya A. Nageswara Rao, Dana J. Wallace, Catherine Billups, James M. Boyett, Amar Gajjar, Roger J. Packer
  • Pediatric Blood & Cancer, August 2013, Wiley
  • DOI: 10.1002/pbc.24670

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1002/pbc.24670

In partnership with:

Link to Wiley showcase

More from this publisher